Nanjing CoreTech Biomedical Co Ltd
Nanjing CoreTech biomedical Co Ltd which is controlled by the Nanjing New Industrial Investment Group was founded in 2002.The company which takes the aim at industrialization is a biomedical research institute. It has two core businesses which are API and intermediate research and industrialization, biomedical R and D outsourcing.
In the aspect of API and pharmaceutical intermediates, the company has successfully developed more than 120 new drugs，of which 70 can be long-term stably supplied to domestic and foreign customers.
The R & D and incubation center of the company is 26,000 square meters. It has built a drug development, life sciences technology and CMO platform
|Sales markets||Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America|
|Primary business activity||Manufacturer|
Our Top products
Nanjing coretech biomedical co,.ltd. Provides wide range of drug intermediates which includes tapentadol hydrochloride. Contact us for more information.More info
Nanjing coretech biomedical co,.ltd. Provides wide range of drugs which includes acotiamide hydrochloride. Appearance: off-white powderr. Contact us for more informationMore info
WebsiteView all contact information
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation